Barry A. Gusterson

22.9k citations

127 papers · 8.6k indexed · 2 hit papers · h-index 46

Oncology top 0.5%
Molecular Biology top 2%
Cancer Research top 0.5%
Genetics top 1%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Torsten Stein Janet Shipley Richard D. Gelber Alan S. Coates Aron Goldhirsch Karen N. Price José Russo Victoria J. Heath
Topics: Cancer Cells and Metastasis (25 papers)Breast Cancer Treatment Studies (18 papers)HER2/EGFR in Cancer Research (15 papers)
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: Journal of Biological Chemistry Nature Genetics Journal of Clinical Oncology
Partner nations: United Kingdom United States Italy

In The Last Decade

Barry A. Gusterson

127 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

1994 606 citations Janet Shipley, Barry A. Gusterson et al. profile →
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

2000 442 citations Işık G. Yuluğ, Barry A. Gusterson et al. profile →

Peers

Countries citing papers authored by Barry A. Gusterson

Since Specialization

Citations

This map shows the geographic impact of Barry A. Gusterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Gusterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Gusterson more than expected).

Fields of papers citing papers by Barry A. Gusterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry A. Gusterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Gusterson. The network helps show where Barry A. Gusterson may publish in the future.

Co-authorship network of co-authors of Barry A. Gusterson

This figure shows the co-authorship network connecting the top 25 collaborators of Barry A. Gusterson. A scholar is included among the top collaborators of Barry A. Gusterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry A. Gusterson. Barry A. Gusterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation 2023 ·EBioMedicine ·Anna Wilkins,Barry A. Gusterson,Holly Tovey,Clare Griffin,(unknown),Frances Daley,Catherine M. Corbishley,David P. Dearnaley,Emma Hall,Navita Somaiah	5
2	De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer 2021 ·Cell Death and Differentiation ·Sylvain Lefort,Amal M. El-Naggar,Susanna Tan,Shane Colborne,Gian Luca Negri,Davide Pellacani,Martin Hirst,Barry A. Gusterson,Gregg B. Morin,Poul H. Sorensen,Connie J. Eaves	4
3	Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer 2010 ·Journal of Clinical Oncology ·Marco Colleoni,Bernard F. Cole,Giuseppe Viale,Meredith M. Regan,Karen N. Price,Eugenio Maiorano,Mauro G. Mastropasqua,Diana Crivellari,Richard D. Gelber,Aron Goldhirsch,Alan S. Coates,Barry A. Gusterson	109
4	A prophylactic vaccine for breast cancer? 2010 ·Breast Cancer Research ·Christine J. Watson,Barry A. Gusterson	6
5	Should we be surprised at the paucity of response to EGFR inhibitors? 2009 ·The Lancet Oncology ·Barry A. Gusterson,Keith D. Hunter	34
6	BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial 2006 ·Cancer Letters ·Zsofia Kote‐Jarai,Trevor J. Powles,Gillian Mitchell,Alwynne Tidy,S. Ashley,Douglas F. Easton,L. Assersohn,Nayanta Sodha,Janine Salter,Barry A. Gusterson,Mitch Dowsett,Rosalind A. Eeles	10
7	Concomitant inactivation of p53 and Chk2 in breast cancer 2002 ·Oncogene ·Alexandra Sullivan,Martin Yuille,Claire E. Repellin,(unknown),Olivier Reelfs,Alexandra Bell,Barbara Dunne,Barry A. Gusterson,Peter Osin,Paul J. Farrell,Işık G. Yuluğ,Abigail Evans,Tayfun Özçelık,Milena Gasco,Tim Crook	67
8	Inhibition of myc-dependent breast tumor formation in transgenic mice 2002 ·Breast Cancer Research and Treatment ·Wei Cui,Barry A. Gusterson,A. John Clark	2
9	Mammary gland patterning in the AXB/BXA recombinant inbred strains of mouse 2000 ·Mechanisms of Development ·Beatrice A. Howard,Barry A. Gusterson	7
10	Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up 1998 ·Human Pathology ·Sunil Badve,Roger A’Hern,(unknown),Rosemary R. Millis,Sarah E. Pinder,Ian O. Ellis,Barry A. Gusterson,J P Sloane	63
11	Differential expression of type XIV collagen/undulin by human mammary gland intralobular and interlobular fibroblasts 1998 ·Cell and Tissue Research ·Amanda J. Atherton,Michael J. Warburton,Michael J. O’Hare,Paul Monaghan,Detlef Schuppan,Barry A. Gusterson	14
12	der(16)t(1;16)(q21;q13) as a secondary change in Alveolar Rhabdomyosarcoma: A case report and review of the literature 1996 ·Cancer Genetics and Cytogenetics ·Aidan McManus,Toon Min,G. John Swansbury,Barry A. Gusterson,CR Pinkerton,Janet Shipley	14
13	Brk, a Breast Tumor-derived Non-receptor Protein-tyrosine Kinase, Sensitizes Mammary Epithelial Cells to Epidermal Growth Factor 1996 ·Journal of Biological Chemistry ·Tahereh Kamalati,Helen E. Jolin,Philip J. Mitchell,Karen Barker,L. Elizabeth Jackson,Christopher Dean,Martin Pagé,Barry A. Gusterson,M. Rufus Crompton	98
14	Additional copies of 1q in sequential samples from a phyllodes tumor of the breast 1995 ·Cancer Genetics and Cytogenetics ·Sandra Birdsall,Brenda Summersgill,(unknown),Ian S. Fentiman,Barry A. Gusterson,Janet Shipley	11
15	Hydrocortisone induces the synthesis of α₂‐macroglobulin by rat mammary myoepithelial cells 1993 ·European Journal of Biochemistry ·Michael J. Warburton,Brian Coles,Sinclair R. Dundas,Barry A. Gusterson,Michael J. O’Hare	6
16	The molecular biology of soft tissue sarcomas 1993 ·European Journal of Cancer ·Janet Shipley,(unknown),Barry A. Gusterson	8
17	Peripubertal human breast development 1990 ·The Anatomical Record ·(unknown),Nina Perusinghe,Philip J. Cowen,Barry A. Gusterson	30
18	Maintenance of normal human breast organoids within rat mammary fat pads in organ culture 1987 ·PubMed ·H. J. Stewart,(unknown),(unknown),Nina Perusinghe,Michael J. O’Hare,Barry A. Gusterson	4
19	Monoclonal antibodies specific for subsets of epidermal keratins: Biochemical and immunocytochemical characterization—applications in pathology and cell culture 1985 ·The Journal of Pathology ·Jenny Knight,Barry A. Gusterson,Robin Russell Jones,(unknown),Patricia D. Wilson	38
20	Primary culture of a primordial cyst from a case of Gorlin's syndrome 1979 ·British Journal of Oral Surgery ·Barry A. Gusterson,Paul Monaghan,(unknown)	2

About Barry A. Gusterson

Barry A. Gusterson is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 127 papers that have together received 8.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (25 papers), Breast Cancer Treatment Studies (18 papers) and HER2/EGFR in Cancer Research (15 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (4.6k citations) and Pathology and Forensic Medicine (1.4k citations). Barry A. Gusterson has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Torsten Stein, Janet Shipley, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch, Karen N. Price, José Russo, Victoria J. Heath, Monica Castiglione‐Gertsch and Giuseppe Viale. Their work appears in journals such as Journal of Biological Chemistry, Nature Genetics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact